Insider filing · KURA

Troy Edward Wilson bought $1.1M of Kura Oncology (KURA)

Executed Aug 17, disclosed Aug 17, the same day.

Over the 21 trading sessions from the disclosed entry session (Aug 17), the stock returned +3.2% (delay-adjusted); from the execution session (Aug 17), +3.2%. Derived: entry at the session's open, exit at the close 20 sessions later.

TW Troy Edward Wilson President and CEO profile →

Troy Edward Wilson (President and CEO) filed 3 Form 4 reports in the trailing twelve months (2 purchases, 1 sale), most often in Kura Oncology, Inc. (KURA). Across 1 priced purchase filing, the average 21-session return was +3.2% from execution and +3.2% from disclosure (delay-adjusted; derived). The largest single filing was $1.2M of KURA (100,000 sh × $12.39, as filed), executed Aug 24.

KURA Kura Oncology, Inc. KURA · Healthcare · 13 filings in 24 months ticker →

Healthcare · Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→